Literature DB >> 25466971

[Improving drug prescribing in the elderly: a new edition of STOPP/START criteria].

E Delgado Silveira1, B Montero Errasquín2, M Muñoz García1, M Vélez-Díaz-Pallarés2, I Lozano Montoya2, C Sánchez-Castellano2, A J Cruz-Jentoft3.   

Abstract

Inappropriate use of drugs in older patients may have an adverse impact on several individual health outcomes, such as increasing the prevalence of adverse drug reactions, morbidity and mortality, and geriatric syndromes, as well as on health care systems, such as increased costs and longer hospital stays. Explicit criteria of drug appropriateness are increasingly used to detect and prevent inappropriate use of drugs, either within a comprehensive geriatric assessment or as tool used by different multidisciplinary geriatric teams. STOPP-START criteria, first published in 2008 (in Spanish in 2009), are being adopted as reference criteria throughout Europe. The Spanish version of the new 2014 edition (recently published in English) of the STOPP-START criteria is presented here. A review of all the papers published in Spain using the former version of these criteria is also presented, with the intention of promoting their use and for research in different health care levels.
Copyright © 2014 SEGG. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Drug-related problems; Explicit criteria; Métodos explícitos; Older people; Pacientes mayores; Polimedicación; Polypharmacy; Potentially inappropriate prescriptions; Prescripción inadecuada; Problemas relacionados con los medicamentos

Mesh:

Year:  2014        PMID: 25466971     DOI: 10.1016/j.regg.2014.10.005

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  15 in total

1.  Spanish list of potentially inappropriate drugs in the elderly (ES-PIA project).

Authors:  Magali Gonzalez-Colaço Harmand; Ana María Aldea-Perona; Carlos Boada-Fernández Del Campo; Almudena Areosa-Sastre; Consuelo Rodríguez-Jiménez; Marcelino García Sánchez-Colomer; Eduardo Fernández Quintana; Mercedes Plasencia-Nuñez; Paula Masiero-Aparicio; Candelaria Grillo-Grillo; Andrés Orellana-Mobilli; Mar García Sáiz; Carmen Duarte Diéguez; Mercedes Hornillos Calvo; Juan Antonio Avellana Zaragoza; Nicolás Martínez Velilla; Domingo de Guzmán Pérez Hernández; Mario Ruiz González; Encarnación Blanco Reina; Carmen Asensio Ostos; Ana Peiró; Lourdes Cabrera García; Fuensanta Hortigüela Moro; Herlinda Pérez Alayón; Iriana Espárrago García; Javier Santana Quilez; Javier Alonso Ramírez; Carlos Fernández Oropesa; Mª José López Varona; Mª Teresa Acín Gerico; Emilio Sanz Alvarez; María Ángeles Martín de la Sierra; María José Peñalver; Teresa Falomir Gómez; Jesús Ruiz Salazar; Gabriela Elizondo Rivas; Edmundo Rey Rodríguez
Journal:  Eur J Clin Pharmacol       Date:  2019-05-08       Impact factor: 2.953

2.  Impact of a Pharmaceutical Care Program at Discharge on Patients at High Risk of Readmission According to the Hospital Score.

Authors:  María Luisa Ibarra Mira; Jose Manuel Caro-Teller; Pedro Pablo Rodríguez Quesada; Carmen Garcia-Muñoz; Almudena Añino Alba; Jose Miguel Ferrari Piquero
Journal:  J Pharm Technol       Date:  2021-09-22

3.  Potentially inappropriate medications in a sample of Portuguese nursing home residents: Does the choice of screening tools matter?

Authors:  Filipa Alves da Costa; Catarina Periquito; Maria Clara Carneiro; Pedro Oliveira; Ana Isabel Fernandes; Patrícia Cavaco-Silva
Journal:  Int J Clin Pharm       Date:  2016-06-24

4.  Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients.

Authors:  E Delgado-Silveira; M S Albiñana-Pérez; M Muñoz-García; M García-Mina Freire; E M Fernandez-Villalba
Journal:  Eur J Hosp Pharm       Date:  2016-11-23

5.  Risk Factors for Emergency Department Short Time Readmission in Stratified Population.

Authors:  Ariadna Besga; Borja Ayerdi; Guillermo Alcalde; Alberto Manzano; Pedro Lopetegui; Manuel Graña; Ana González-Pinto
Journal:  Biomed Res Int       Date:  2015-11-17       Impact factor: 3.411

6.  Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.

Authors:  Marisa Baré; Susana Herranz; Rosa Jordana; Maria Queralt Gorgas; Sara Ortonobes; Daniel Sevilla; Elisabet De Jaime; Olatz Ibarra; Candelaria Martín
Journal:  BMJ Open       Date:  2020-01-26       Impact factor: 2.692

7.  Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management.

Authors:  Luis Agüera-Ortiz; Rocío García-Ramos; Francisco J Grandas Pérez; Jorge López-Álvarez; José Manuel Montes Rodríguez; F Javier Olazarán Rodríguez; Javier Olivera Pueyo; Carmelo Pelegrin Valero; Jesús Porta-Etessam
Journal:  Front Psychiatry       Date:  2021-02-26       Impact factor: 4.157

8.  [Impact of medium-term outcomes of inappropriate prescribing in older patients discharged from a short stay unit].

Authors:  Elena Rodríguez Del Río; Javier Perdigones; Manuel Fuentes Ferrer; Juan González Del Castillo; Juan González Armengol; M Isabel Borrego Hernando; M Lourdes Arias Fernández; Francisco Javier Martín-Sánchez
Journal:  Aten Primaria       Date:  2017-10-25       Impact factor: 1.137

9.  Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study.

Authors:  Eloisa Rogero-Blanco; Juan A Lopez-Rodriguez; Teresa Sanz-Cuesta; Mercedes Aza-Pascual-Salcedo; M Jose Bujalance-Zafra; Isabel Cura-Gonzalez
Journal:  JMIR Med Inform       Date:  2020-03-03

10.  Tackling frailty at primary care: evaluation of the effectiveness of a multicomponent intervention through a randomised controlled trial: study protocol.

Authors:  Francisco Rivas-Ruiz; Mónica Machón; Maider Mateo-Abad; Eugenio Contreras-Fernández; Carolina Güell; Luis Baro-Rodríguez; Kalliopi Vrotsou; Raúl Quirós-López; Itziar Vergara
Journal:  BMJ Open       Date:  2020-02-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.